Soluble ST2, a preeclampsia-related cytokine receptor, is transported bi-directionally across the placenta.

Placenta

Laboratory of Molecular and Translational Medicine, Center for Translational Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, P.R. China. Electronic address:

Published: March 2018

Introduction: We aimed to elucidate whether soluble ST2 (sST2), a preeclampsia (PE)-related cytokine, in the maternal or fetal circulation could be transported to the other circulatory system across the placenta.

Methods: A placental perfusion model in a closed system was established and optimized. HPLC was performed to determine the dynamics of antipyrine levels in the perfusate. Placentas (n = 18) collected from healthy controls and PE patients were perfused without additional treatment or with added sST2 in the maternal or fetal circulation. The concentration of sST2 in the perfusate samples was quantified by ELISA.

Results: Monitoring of the antipyrine levels were used as a quality control and showed each placenta established successfully. In the untreated group, sST2 could be produced by the placenta and enter into both the maternal and fetal circulations, and significantly higher levels were detected in the maternal circulation. In placentas perfused with additional sST2 in the maternal circulation, a similar trend was observed as for the untreated placentas. When sST2 was added to the fetal circulation, increased sST2 was detected in the maternal circulation. Compared with the healthy controls, significantly elevated sST2 in the maternal side of PE patients were detected.

Conclusion: Soluble ST2 could be bi-directionally transported across placentas. It was an active process that maintained a higher level of sST2 in the maternal circulation. Furthermore, the significant increase of sST2 in the maternal blood of PE patients was due to an impaired placental barrier as a result of PE.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.placenta.2018.01.003DOI Listing

Publication Analysis

Top Keywords

sst2 maternal
20
maternal circulation
16
soluble st2
12
maternal fetal
12
fetal circulation
12
sst2
10
maternal
9
antipyrine levels
8
healthy controls
8
perfused additional
8

Similar Publications

Article Synopsis
  • This study investigates the potential of three biomarkers (REG3α, sST2, and TNFR1) in blood as predictors for the severity and outcome of acute graft-versus-host disease (aGVHD) in children post-transplant.
  • Data from 70 aGVHD patients and 30 healthy children were analyzed, revealing higher levels of these biomarkers in more severe cases of aGVHD and in those with poor treatment outcomes.
  • The combined analysis of all three markers showed enhanced predictive accuracy for aGVHD prognosis, outperforming the use of each marker individually or in pairs.
View Article and Find Full Text PDF

A biomarker for bacteremia in pregnant women with acute pyelonephritis: soluble suppressor of tumorigenicity 2 or sST2.

J Matern Fetal Neonatal Med

December 2023

Pregnancy Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS), Bethesda, MD, and Detroit, MI, USA.

Sepsis is a leading cause of maternal death, and its diagnosis during the golden hour is critical to improve survival. Acute pyelonephritis in pregnancy is a risk factor for obstetrical and medical complications, and it is a major cause of sepsis, as bacteremia complicates 15-20% of pyelonephritis episodes in pregnancy. The diagnosis of bacteremia currently relies on blood cultures, whereas a rapid test could allow timely management and improved outcomes.

View Article and Find Full Text PDF

Soluble suppression of tumorigenicity-2 in pregnancy with a small-for-gestational-age fetus and with preeclampsia.

J Matern Fetal Neonatal Med

December 2023

Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, United States Department of Health and Human Services, Detroit, MI, USA.

Objective: Preeclampsia and fetal growth disorders are pregnancy-specific conditions that share common pathophysiological mechanisms. Yet, why some patients develop preeclampsia while others experience fetal growth restriction, or a combination of both clinical presentations, is unknown. We propose that the difference in severity of the maternal inflammatory response can contribute to the clinical phenotypes of preeclampsia vs.

View Article and Find Full Text PDF

The primary objective of this study was to determine the longitudinal profile of serum sST2 (soluble suppression of tumorigenicity 2), IL-33 (interleukin-33) and NT-proBNP (N-terminal pro-brain natriuretic peptide) concentrations in twin pregnancies with pre-eclampsia (PE) and those normotensive twins. The secondary objective was to test whether the change of serum sST2,IL-33 and NT-proBNP is related to PE in twin pregnancies. This is a longitudinal nested case-control study and all 156 dichorionic (DC) pregnancies were from a prospective cohort of twin pregnancies who received antenatal care and gave two live births at Peking University Third Hospital between October 2017 and September 2020.

View Article and Find Full Text PDF

An imbalance of the IL-33/ST2-AXL-efferocytosis axis induces pregnancy loss through metabolic reprogramming of decidual macrophages.

Cell Mol Life Sci

March 2022

Laboratory for Reproductive Immunology, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai, 200080, China.

Article Synopsis
  • Efferocytosis, the process where macrophages clear apoptotic cells during embryo implantation, is linked to the immune behavior of decidual macrophages (dMΦs) and can affect pregnancy outcomes.
  • The study discovered that in patients with recurrent pregnancy loss (RPL), there was a disruption in the IL-33/ST2 signaling pathway, leading to increased apoptotic cells and altered metabolism in dMΦs, which contributed to the polarization toward a more inflammatory M1 phenotype.
  • Furthermore, the positive feedback loop involving IL-33/ST2 and AXL in efferocytosis may drive pregnancy failure, as demonstrated in both human samples and experiments with IL-33 knockout mice, highlighting the importance of immunometabolism
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!